PH12013500916A1 - Method for inhibiting pathogens using a nutritional composition - Google Patents

Method for inhibiting pathogens using a nutritional composition

Info

Publication number: PH12013500916A1
Authority: PH; Philippines
Prior art keywords: nutritional composition; inhibiting; inhibiting pathogens; human; pathogens
Prior art date: 2010-12-29

Application number

PH1/2013/500916A

Other languages

English (en)

Inventor

Dattatreya Banavara

Robert J Mcmahon

Cecilia Munoz

Anja Wittke

Original Assignee

Mjn Us Holdings Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-12-29

Filing date

2011-12-15

Publication date

2024-06-03

2010-12-29 Priority claimed from US12/980,813 external-priority patent/US8648036B2/en

2010-12-29 Priority claimed from US12/980,808 external-priority patent/US20120171163A1/en

2011-12-15 Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc

2024-06-03 Publication of PH12013500916A1 publication Critical patent/PH12013500916A1/en

Links

230000002401 inhibitory effect Effects 0.000 title abstract 2
235000016709 nutrition Nutrition 0.000 title abstract 2
244000052769 pathogen Species 0.000 title 1
102000010445 Lactoferrin Human genes 0.000 abstract 1
108010063045 Lactoferrin Proteins 0.000 abstract 1
230000010062 adhesion mechanism Effects 0.000 abstract 1
230000001580 bacterial effect Effects 0.000 abstract 1
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 abstract 1
229940078795 lactoferrin Drugs 0.000 abstract 1
235000021242 lactoferrin Nutrition 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
235000013406 prebiotics Nutrition 0.000 abstract 1
235000018102 proteins Nutrition 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Gastroenterology & Hepatology (AREA)
Pediatric Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PH1/2013/500916A 2010-12-29 2011-12-15 Method for inhibiting pathogens using a nutritional composition PH12013500916A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US12/980,813 US8648036B2 (en)	2010-12-29	2010-12-29	Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
US12/980,808 US20120171163A1 (en)	2010-12-29	2010-12-29	Method for inhibiting a bacterial invasive mechanism using a nutritional composition
PCT/US2011/065231 WO2012091946A2 (fr)	2010-12-29	2011-12-15	Procédé pour l'inhibition de pathogènes en utilisant une composition nutritionnelle

Publications (1)

Publication Number	Publication Date
PH12013500916A1 true PH12013500916A1 (en)	2024-06-03

Family

ID=45496273

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH1/2013/500916A PH12013500916A1 (en)	2010-12-29	2011-12-15	Method for inhibiting pathogens using a nutritional composition

Country Status (13)

Country	Link
EP (1)	EP2658388A2 (fr)
CN (1)	CN103327828B (fr)
BR (1)	BR112013011642B1 (fr)
CA (1)	CA2822892C (fr)
EC (1)	ECSP13012798A (fr)
MX (1)	MX2013006094A (fr)
MY (1)	MY174494A (fr)
PE (1)	PE20141192A1 (fr)
PH (1)	PH12013500916A1 (fr)
RU (1)	RU2013128920A (fr)
SG (2)	SG190781A1 (fr)
TW (1)	TWI626893B (fr)
WO (1)	WO2012091946A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8968722B2 (en)	2010-12-29	2015-03-03	Mead Johnson Nutrition Company	Milk-based nutritional compositions containing lactoferrin and uses thereof
WO2014099134A1 (fr) *	2012-12-18	2014-06-26	Mjn U.S. Holdings Llc	Compositions nutritionnelles à base de lait contenant de la lactoferrine et ses utilisations
US20140271978A1 (en) *	2013-03-15	2014-09-18	Mead Johnson Nutrition Company	Low-buffer nutritional compositions and uses thereof
US9609888B2 (en) *	2013-07-31	2017-04-04	Mead Johnson Nutrition Company	Nutritional compositions containing synergistic combination and uses thereof
US20200276321A1 (en) *	2017-09-10	2020-09-03	Technion Research & Development Foundation Limited	Composition and method for a prebiotic delivery system targeted to probiotic bacteria
GB2618609A (en) *	2022-05-13	2023-11-15	Lintbells Ltd	Methods and processes for manufacture of a topically adherent selective bactericide
CN120051217A (zh)	2022-09-14	2025-05-27	N·V·努特里奇亚	营养组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE61701B1 (en)	1986-07-17	1994-11-30	Morinaga Milk Industry Co Ltd	Process for producing bovine lactoferrin in high purity
US4977137B1 (en) *	1987-06-03	1994-06-28	Baylor College Medicine	Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5407957A (en)	1990-02-13	1995-04-18	Martek Corporation	Production of docosahexaenoic acid by dinoflagellates
CA2101274C (fr)	1991-01-24	1998-12-15	David J. Kyle	Melanges d'huiles de microorganismes et leurs usages
US5374567A (en)	1993-05-20	1994-12-20	The United States Of America As Represented By The Secretary Of The Navy	Operational amplifier using bipolar junction transistors in silicon-on-sapphire
EP0744901B1 (fr)	1994-02-16	2001-12-05	Pharming Intellectual Property BV	Isolation de la lactoferrine du lait
EP1480524B1 (fr)	2002-03-07	2013-04-17	Upfront Chromatography A/S	Procede d'isolement de lactoferrine
US20070191264A1 (en) *	2005-05-05	2007-08-16	Bristol-Myers Squibb Company, A Delaware Corporation	Methods for inhibiting the growth of bacteria
CN101247823A (zh) *	2005-05-05	2008-08-20	布里斯托尔-迈尔斯斯奎布公司	牛乳铁蛋白在制备抑制细菌生长的药物中的用途
US7572474B2 (en)	2005-06-01	2009-08-11	Mead Johnson Nutrition Company	Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US20080003329A1 (en) *	2006-06-30	2008-01-03	Ricardo Rueda	Enriched infant formulas
WO2008047391A1 (fr) *	2006-10-17	2008-04-24	S.I.F.Fr.A. Farmaceutici Srl	Composition nutraceutique comprenant de la lactoferrine et des probiotiques protéasiques
BRPI0819445A2 (pt) *	2007-11-26	2015-12-22	Nestec Sa	sistema de nutrição para recém-nascidos adaptado à idade
ITRM20080163A1 (it) *	2008-03-26	2009-09-27	Maurizio Acri	Uso della lattoferrina per la prevenzione delle sepsi neonatali in neonati prematuri
US8425955B2 (en) *	2009-02-12	2013-04-23	Mead Johnson Nutrition Company	Nutritional composition with prebiotic component
EP2493336A1 (fr) *	2009-10-29	2012-09-05	Nestec S.A.	Compositions nutritionnelles contenant de la lactoferrine et des probiotiques, et nécessaires associés

2011
- 2011-12-15 CA CA2822892A patent/CA2822892C/fr active Active
- 2011-12-15 SG SG2013035944A patent/SG190781A1/en unknown
- 2011-12-15 CN CN201180063052.8A patent/CN103327828B/zh active Active
- 2011-12-15 PE PE2013001284A patent/PE20141192A1/es not_active Application Discontinuation
- 2011-12-15 BR BR112013011642A patent/BR112013011642B1/pt not_active IP Right Cessation
- 2011-12-15 PH PH1/2013/500916A patent/PH12013500916A1/en unknown
- 2011-12-15 RU RU2013128920/15A patent/RU2013128920A/ru not_active Application Discontinuation
- 2011-12-15 MX MX2013006094A patent/MX2013006094A/es unknown
- 2011-12-15 EP EP11809005.9A patent/EP2658388A2/fr not_active Ceased
- 2011-12-15 SG SG10201508194RA patent/SG10201508194RA/en unknown
- 2011-12-15 WO PCT/US2011/065231 patent/WO2012091946A2/fr not_active Ceased
- 2011-12-15 MY MYPI2013001689A patent/MY174494A/en unknown
- 2011-12-26 TW TW100148650A patent/TWI626893B/zh not_active IP Right Cessation
2013
- 2013-07-29 EC ECSP13012798 patent/ECSP13012798A/es unknown

Also Published As

Publication number	Publication date
EP2658388A2 (fr)	2013-11-06
CA2822892A1 (fr)	2012-07-05
CN103327828A (zh)	2013-09-25
CN103327828B (zh)	2016-05-11
PE20141192A1 (es)	2014-10-01
ECSP13012798A (es)	2013-09-30
TWI626893B (zh)	2018-06-21
HK1189456A1 (zh)	2014-06-13
MY174494A (en)	2020-04-23
TW201238503A (en)	2012-10-01
BR112013011642B1 (pt)	2020-04-07
WO2012091946A2 (fr)	2012-07-05
WO2012091946A3 (fr)	2012-09-07
SG10201508194RA (en)	2015-11-27
SG190781A1 (en)	2013-07-31
BR112013011642A2 (pt)	2016-07-12
RU2013128920A (ru)	2015-02-10
CA2822892C (fr)	2020-04-28
MX2013006094A (es)	2013-07-03

Publication	Publication Date	Title
PH12013500916A1 (en)	2024-06-03	Method for inhibiting pathogens using a nutritional composition
IN2014DN03449A (fr)	2015-06-05
MX350325B (es)	2017-09-04	Bacteria para usarse como un probiotico para aplicaciones nutricionales y medicas.
EA201070419A1 (ru)	2011-02-28	Состав для регулирования метаболизма липидов
MX342733B (es)	2016-10-11	Composicion nutricional para promover el desarrollo y crecimiento sano.
PH12013501877A1 (en)	2019-10-07	Nutritional compositions including branched chain fatty acids and methods of using same
PH12012502318A1 (en)	2022-03-21	Substantially clear nutritional liquids comprising calcium hmb and soluble protein
BR112014009418A2 (pt)	2017-04-18	macrociclos peptidomiméticos
WO2013028555A3 (fr)	2013-05-10	Procédés pour la perte de poids et compositions cétogènes
MY158504A (en)	2016-10-14	Fatty acid niacin conjugates and their uses
MY151018A (en)	2014-03-31	Use of nutritional compositions for preventing disorders
BR112013028709A2 (pt)	2017-01-24	cepas bacterianas capazes de metabolizar oxalatos
MX2018009945A (es)	2020-09-02	Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
GB201317630D0 (en)	2013-11-20	Improvements in or relating to visual performance and/or macular pigmentation in a subject and AMD
PH12014500558A1 (en)	2014-04-14	Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
MX338245B (es)	2016-04-08	Metodos y composicioes para inducir la saciedad.
WO2010007332A3 (fr)	2010-04-22	Composition de maltodextrines branchees et d'organismes eucaryotes dotes d'une paroi polysaccharidique utilisees dans le domaine du bien etre
MX343326B (es)	2016-11-01	Metodos para mejorar el metabolismo energetico.
PH12014500796A1 (en)	2022-05-11	Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
UA108465C2 (en)	2015-05-12	Biologically active food supplements
BR112014027820A2 (pt)	2017-06-27	controle dietário de doença celíaca e alergias alimentares
MY161933A (en)	2017-05-15	Fortified Milk-Based Nutritional Compositions
PH12013500917A1 (en)	2024-06-03	Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
EP2588070B8 (fr)	2019-07-24	Utilisation d'acide chicorique et de bactérie lactique pour éclaircir et / ou blanchir le teint
PH12013500761A1 (en)	2017-08-23	Cysteine and food intake